Novocure falls after late-stage trial setback for cancer treatment device

ECARX GAAP EPS of -$0.03, revenue of $225.2M misses by $1.36M; reaffirms FY 2026 outlook

2026/08/11

Upstream Bio, Inc. reports Q2 results

2026/08/11

Anthropic's data center deal with Riot likely a boon for AMD, Wedbush says

2026/08/11

Beyond Meat to execute 1-for-30 reverse stock split

2026/08/11